RIL
Rothschild Investment LLC Portfolio holdings
AUM
$1.6B
1-Year Return
17.99%
This Quarter Return
+9.71%
1 Year Return
+17.99%
3 Year Return
+73.94%
5 Year Return
+135.61%
10 Year Return
+254.21%
AUM
$1.6B
AUM Growth
+$101M
(+6.8%)
Cap. Flow
-$4.27M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
3,233
New
209
Increased
1,380
Reduced
863
Closed
217
Top Buys
Top Sells
| 1 |
Novo Nordisk
NVO
|
+$7.27M |
| 2 |
Kenvue
KVUE
|
+$4.89M |
| 3 |
FPF
First Trust Intermediate Duration Preferred & Income Fund
FPF
|
+$3.13M |
| 4 |
Nuveen Preferred & Income Opportunities Fund
JPC
|
+$2.87M |
| 5 |
Apple
AAPL
|
+$2.73M |
Sector Composition
| 1 | Technology | 18.15% |
| 2 | Financials | 13.7% |
| 3 | Industrials | 9.06% |
| 4 | Healthcare | 7.79% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Enviri
NVRI
$983M
| $2.26K | ﹤0.01% |
260
+160
| +160% | +$1.39K |
|
1977
Intellia Therapeutics
NTLA
$1.23B
| $2.25K | ﹤0.01% |
240
+85
| +55% | +$797 |
|
1978
MGP Ingredients
MGPI
$596M
| $2.25K | ﹤0.01% |
75
-35
| -32% | -$1.05K |
|
1979
Celldex Therapeutics
CLDX
$1.62B
| $2.24K | ﹤0.01% |
110
+20
| +22% | +$407 |
|
1980
F&G Annuities & Life
FG
$4.65B
| $2.24K | ﹤0.01% |
70
+40
| +133% | +$1.28K |
|
1981
Grocery Outlet
GO
$1.74B
| $2.24K | ﹤0.01% |
+180
| New | +$2.24K |
|
1982
eXp World Holdings
EXPI
$1.75B
| $2.23K | ﹤0.01% |
245
+170
| +227% | +$1.55K |
|
1983
La-Z-Boy
LZB
$1.39B
| $2.23K | ﹤0.01% |
60
-25
| -29% | -$929 |
|
1984
Innovator US Equity Power Buffer ETF October
POCT
$775M
| $2.23K | ﹤0.01% |
54
| – | – |
|
1985
Towne Bank
TOWN
$2.83B
| $2.22K | ﹤0.01% |
65
-70
| -52% | -$2.39K |
|
1986
Nurix Therapeutics
NRIX
$691M
| $2.22K | ﹤0.01% |
195
+35
| +22% | +$399 |
|
|
CIM
1987
Chimera Investment
CIM
$1.15B
| $2.22K | ﹤0.01% |
160
-35
| -18% | -$485 |
|
1988
AdaptHealth
AHCO
$1.26B
| $2.22K | ﹤0.01% |
235
+90
| +62% | +$849 |
|
|
CIO
1989
City Office REIT
CIO
$280M
| $2.22K | ﹤0.01% |
415
+315
| +315% | +$1.68K |
|
1990
Diebold Nixdorf
DBD
$2.17B
| $2.22K | ﹤0.01% |
40
| – | – |
|
1991
United Natural Foods
UNFI
$1.77B
| $2.21K | ﹤0.01% |
95
| – | – |
|
1992
Douglas Dynamics
PLOW
$752M
| $2.21K | ﹤0.01% |
75
-5
| -6% | -$147 |
|
1993
IAMGOLD
IAG
$6.42B
| $2.21K | ﹤0.01% |
300
| – | – |
|
1994
P10
PX
$1.33B
| $2.2K | ﹤0.01% |
215
+155
| +258% | +$1.58K |
|
|
FARO
1995
DELISTED
Faro Technologies
FARO
| $2.2K | ﹤0.01% |
50
+35
| +233% | +$1.54K |
|
1996
Janux Therapeutics
JANX
$1.45B
| $2.2K | ﹤0.01% |
95
+50
| +111% | +$1.16K |
|
|
ACRE
1997
Ares Commercial Real Estate
ACRE
$266M
| $2.19K | ﹤0.01% |
460
+215
| +88% | +$1.03K |
|
1998
Sapiens International
SPNS
$2.4B
| $2.19K | ﹤0.01% |
75
-5
| -6% | -$146 |
|
1999
Enanta Pharmaceuticals
ENTA
$177M
| $2.19K | ﹤0.01% |
290
+265
| +1,060% | +$2K |
|
2000
DXP Enterprises
DXPE
$1.85B
| $2.19K | ﹤0.01% |
25
+5
| +25% | +$438 |
|